Here's another line that stood out for me. Would like to hear more about this.
43. 58:35 Will have interim analysis of CD16 and will have DSMC look at that. If interim results p-value is statistically significant MHRA will (accept?) that. Pretty sure the FDA will too.
There are no guarantees in investing. No one should consider these pages or posts to be financial advice. Everyone has a responsibility to verify and thoroughly learn more than what is referenced or written here, and everyone must take responsibility for their own investing decisions.